CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 3
- ScaleMarket cap is $1.47B, above the global median of $1.15B
- FinancialsAltman Z-Score 12.83: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.91BCNY1.47B · vs all stocks (USD)
Revenue (TTM)
427.66MCNY63.60M · vs all stocks (USD)
Profit Margin
-57.69%vs Biotechnology peers
Beta
0.3940xvs all stocks
52-Week Change
-53.76%vs all stocks
Market Capitalization
9.91BCNY1.47B · vs all stocks (USD)
Enterprise Value
8.16BCNY1.21B · vs all stocks (USD)
Price to Sales (TTM)
24.11xvs Biotechnology peers
Price to Book (MRQ)
4.04xvs Biotechnology peers
Enterprise to Revenue
19.07xvs Biotechnology peers
Enterprise to EBITDA
-35.71xvs Biotechnology peers
Gross Margin
52.50%vs Biotechnology peers
Profit Margin
-57.69%vs Biotechnology peers
Operating Margin
-71.18%vs Biotechnology peers
Return on Assets (TTM)
-6.03%vs Biotechnology peers
Return on Equity (TTM)
-10.68%vs Biotechnology peers
Revenue (TTM)
427.66MCNY63.60M · vs all stocks (USD)
Revenue per Share (TTM)
4.65CNYUpdated Aug 21, 2026Quarterly Revenue Growth
24.40%vs Biotechnology peers
Gross Profit (TTM)
247.31MCNY36.78M · vs all stocks (USD)
EBITDA (TTM)
-228.36MCNY-33.96M · vs all stocks (USD)
Net Income (TTM)
-246.70MCNY-36.69M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-6.98%vs Biotechnology peers
Operating Cash Flow (TTM)
-133.94MCNY-19.92M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-176.70MCNY-26.28M · vs all stocks (USD)
Payout Ratio
0.00%vs Biotechnology peers
Minority Interest (Equity)
170.32MCNYFY2025 · Dec 31, 2025Revenue
404.88MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
171.78MCNYFY2025 · Dec 31, 2025Gross Profit
233.09MCNYFY2025 · Dec 31, 2025Operating Income
-249.47MCNY-37.10M · vs all stocks (USD)
Pre-tax Income
-267.28MCNYFY2025 · Dec 31, 2025Income Tax Expense
-8.64MCNYFY2025 · Dec 31, 2025Net Income
-258.63MCNYFY2025 · Dec 31, 2025EBIT
-258.48MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-90.57MCNYFY2025 · Dec 31, 2025Research & Development
162.28MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
130.50MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
21.44MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
8.80MCNYFY2025 · Dec 31, 2025EPS (Basic)
-2.50CNYFY2025 · Dec 31, 2025EPS (Diluted)
-2.50CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
86.42MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
86.42MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-258.63MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
42.59MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-186.56MCNYFY2025 · Dec 31, 2025Free Cash Flow
-228.43MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
536.83MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-258.63MCNYFY2025 · Dec 31, 2025Other Non-cash Items
16.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
51.24MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
4.62MCNYFY2025 · Dec 31, 2025Capital Expenditures
-41.87MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.70BCNYFY2025 · Dec 31, 2025Sale of Investments
4.99BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
248.92MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
321.18MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-46.82MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.74MCNYFY2025 · Dec 31, 2025Other Financing Charges
-184.84MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
87.78MCNYFY2025 · Dec 31, 2025Shares Outstanding
92.71MSharesUpdated Aug 21, 2026Float Shares
60.15MSharesUpdated Aug 21, 2026% Held by Insiders
32.20%vs all stocks
% Held by Institutions
24.62%vs all stocks
Total Cash (MRQ)
1.21BCNY180.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
13.73CNYUpdated Aug 21, 2026Total Debt (MRQ)
3.84MCNY570.65K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0015xvs Biotechnology peers
Current Ratio (MRQ)
6.74xvs Biotechnology peers
Book Value per Share (MRQ)
27.52CNYUpdated Aug 21, 2026Total Assets
3.18BCNY472.88M · vs all stocks (USD)
Total Current Assets
1.60BCNYFY2025 · Dec 31, 2025Total Liabilities
523.29MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.58BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
275.25MCNYFY2025 · Dec 31, 2025Total Current Liabilities
248.03MCNYFY2025 · Dec 31, 2025Cash
534.09MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.75MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
536.84MCNYFY2025 · Dec 31, 2025Other Short-term Investments
830.33MCNYFY2025 · Dec 31, 2025Accounts Receivable
118.03MCNYFY2025 · Dec 31, 2025Inventory
79.36MCNYFY2025 · Dec 31, 2025Accounts Payable
105.21MCNYFY2025 · Dec 31, 2025Short-term Debt
50.36MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.38MCNYFY2025 · Dec 31, 2025Long-term Debt
130.44KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
264.05MCNYFY2025 · Dec 31, 2025Common Stock (Book)
92.71MCNYFY2025 · Dec 31, 2025Retained Earnings
2.50BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.66BCNY395.06M · vs all stocks (USD)
Treasury Stock
338.55MCNYFY2025 · Dec 31, 202552-Week Low
73.44CNYUpdated Aug 21, 202652-Week High
249.89CNYUpdated Aug 21, 202652-Week Change
-53.76%vs all stocks
Beta
0.3940xvs all stocks
50-Day MA
106.28CNYUpdated Aug 21, 2026200-Day MA
130.04CNYUpdated Aug 21, 2026Avg 10-Day Volume
5.24MSharesUpdated Aug 21, 2026Avg 30-Day Volume
4.87MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-2.84CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.53Profit Margin: -0.58
Financial Health
Altman Z-Score 12.83: safe zoneNotable
Altman Z-Score: 12.83
Supply Chain
Upstream position: supplies 6 industries, depends on 3Notable
Outgoing: 6.00Incoming: 3.00
Scale
Market cap is $1.47B, above the global median of $1.15BNotable
Market cap (USD): 1,473,417,887.524Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Concord Biotech Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Vcanbio Cell & Gene Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inspire Medical Systems, Inc.
Tier 1ProductionApproval-Gated PipelineRule
China Traditional Chinese Medicine Holdings Co. Limited
Tier 1ProductionApproval-Gated PipelineFlowInterface
Integra LifeSciences Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Jolly Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Olix Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shandong Xinhua Pharmaceutical Company Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pacific Shuanglin Bio-Pharmacy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Septarna Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Wintao Communications Co.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shenzhen Uugreenpower Electric Co., Ltd.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Forward Industries, Inc.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated